AzTrials
AzTrials

Motoric Cognitive Risk Syndrome8FWT-MCRNCT07586553

Figure-of-8 Walk Test in Individuals With Motoric Cognitive Risk Syndrome

An observational study of Motoric Cognitive Risk Syndrome and Gait, run by Balikesir University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This observational study aims to investigate the validity and reliability of the Figure-of-8 Walk Test (8FWT) in individuals with Motoric Cognitive Risk Syndrome (MCRS). The study will evaluate test-retest reliability, measurement error (SEM, MDC), and construct validity by examining the relationship between 8FWT… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Motoric Cognitive Risk Syndrome, Gait, Balance
What is being tested?
Assessment Protocol
How many people
52 participants
Where
1 siteTurkey (Türkiye)
Study dates
7 Apr 2026to 8 Jul 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: This study will include community-dwelling older adults aged 65 years and above diagnosed with Motoric Cognitive Risk Syndrome (MCRS) and living in Balıkesir, Turkey. Participants will be recruited from individuals attending the Tazelenme University Coordination Unit. All participants will be able to walk independently and have sufficient cognitive and physical capacity to complete the assessment protocol.

Who may be able to join

  • Aged 65 years or older Presence of subjective cognitive complaints Gait speed ≤ 0.8 m/s (4-meter walk test) Able to walk independently without assistive devices No clinical diagnosis of dementia Able to understand and follow test instructions

Who cannot join

  • Mini-Mental State Examination (MMSE) score < 24 Neurological diseases affecting gait (e.g., stroke, Parkinson's disease, multiple sclerosis) Severe musculoskeletal conditions affecting walking Lower extremity surgery within the last 6 months Severe visual or hearing impairment that interferes with testing Dependence on assistive walking devices

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ebru Tekin, Lecturer contact

+90 266 614 69 11

ebrutekin123@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Balikesir University

    Balıkesir, Bigadiç

    Ebru Tekin, +90 266 614 69 11, ebrutekin123@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Validity and Reliability of the Figure-of-8 Walk Test (8FWT) in Individuals With Motoric Cognitive Risk Syndrome

This observational study aims to investigate the validity and reliability of the Figure-of-8 Walk Test (8FWT) in individuals with Motoric Cognitive Risk Syndrome (MCRS). The study will evaluate test-retest reliability, measurement error (SEM, MDC), and construct validity by examining the relationship between 8FWT performance and functional mobility measures. The findings are expected to provide evidence for the clinical applicability of 8FWT in assessing dynamic balance, gait performance, and cognitive-motor interaction in older adults.

Being tested
Assessment Protocol

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment ProtocolOther

    Participants will undergo a series of non-invasive assessments including the Figure-of-8 Walk Test (8FWT) and Timed Up and Go (TUG) test to evaluate gait performance, dynamic balance, and cognitive-motor interaction. No therapeutic intervention will be applied.

Study groups in NCT07586553
Study groupRoleWhat they receive
Motoric Cognitive Risk Syndrome GroupCommunity-dwelling older adults aged 65 years and above diagnosed with Motoric Cognitive Risk Syndrome who will undergo functional mobility and gait assessments.
Receives: Other: Assessment Protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Figure-of-8 Walk Test completion time

    Time required to complete the Figure-of-8 Walk Test will be recorded in seconds.

    Measured: Baseline

  2. Figure-of-8 Walk Test number of steps

    The number of steps taken during the Figure-of-8 Walk Test will be recorded.

    Measured: Baseline

  3. Figure-of-8 Walk Test walking speed

    Walking speed during the Figure-of-8 Walk Test will be calculated in meters per second.

    Measured: Baseline

Secondary outcomes (4)
  1. Timed Up and Go Test completion time

    Time required to stand up from a chair, walk 3 meters, turn, return, and sit down will be recorded in seconds.

    Measured: Baseline

  2. Test-retest reliability of the Figure-of-8 Walk Test

    Intraclass Correlation Coefficient (ICC) will be calculated to determine the reliability of repeated 8FWT measurements.

    Measured: Baseline and 7 days after baseline

  3. Standard Error of Measurement of the Figure-of-8 Walk Test

    Standard Error of Measurement will be calculated to quantify the measurement precision of the Figure-of-8 Walk Test.

    Measured: Baseline and 7 days after baseline

  4. Minimal Detectable Change of the Figure-of-8 Walk Test

    Minimal Detectable Change will be calculated to quantify the smallest change exceeding measurement error for the Figure-of-8 Walk Test.

    Measured: Baseline and 7 days after baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2026
  2. Study start7 Apr 2026
  3. Primary completion28 Apr 2026
  4. Study completion8 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07586553
Sponsor's protocol ID
2026/52
Acronym
8FWT-MCR
Status last verified
May 2026
First submitted
1 May 2026
Last updated
14 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Montero-Odasso M, Verghese J, Beauchet O, Hausdorff JM. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012 Nov;60(11):2127-36. doi: 10.1111/j.1532-5415.2012.04209.x. Epub 2012 Oct 30.

    PubMed 23110433
  • Huang, Z., Zheng, R., He, M., & Wang, J. (2024). Motoric cognitive risk syndrome and incident dementia: A systematic review and meta-analysis. International Journal of Geriatric Psychiatry, 39(2), e6055. https://doi.org/10.1002/gps.6055

  • Kong HH, Shin K, Yang DS, Gu HY, Joo HS, Shon HC. Digital assessment of walking ability: Validity and reliability of the automated figure-of-eight walk test in older adults. PLoS One. 2025 Feb 10;20(2):e0316612. doi: 10.1371/journal.pone.0316612. eCollection 2025.

    PubMed 39928640
  • Coyle PC, Perera S, Shuman V, VanSwearingen J, Brach JS. Development and Validation of Person-Centered Cut-Points for the Figure-of-8-Walk Test of Mobility in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2020 Nov 13;75(12):2404-2411. doi: 10.1093/gerona/glaa035.

    PubMed 32006022
  • Hess RJ, Brach JS, Piva SR, VanSwearingen JM. Walking skill can be assessed in older adults: validity of the Figure-of-8 Walk Test. Phys Ther. 2010 Jan;90(1):89-99. doi: 10.2522/ptj.20080121. Epub 2009 Dec 3.

    PubMed 19959654

Questions about this trial

What is this clinical trial studying?

An observational study of Motoric Cognitive Risk Syndrome and Gait, run by Balikesir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ebru Tekin, Lecturer (+90 266 614 69 11, ebrutekin123@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Figure-of-8 Walk Test completion time (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07586553, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in